KIR2DL1 and hepatocellular carcinoma: We previously examined the role of KIR–HLA in HCV-related HCC in a cross-sectional study and revealed that KIR2DL1 + HLA-C1 was associated with younger onset (<65 years old) HCV-related HCC [15].